References
- Patton JP, Nash DB, Abrutyn E. Urinary tract infection: economic considerations. Med Clin North Am 1991; 75(2): 495–513
- Johnson CC. Definitions, classification, and clinical presentation of urinary tract infections. Med Clin North Am 1991; 75(2): 241–52
- Daifiiku R, Stamm WE. Association of rectal and urethral colonization with urinary tract infection in patients with indwelling catheters. JAMA 1984; 252(15): 2028–30
- Sobel JD. Bacterial etiologic agents in the pathogenesis of urinary tract infection. Med Clin North Am 1991; 75(2): 253–73
- Schaeffer AJ, Schwan WR, Hultgren SJ, et al. Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice. Infect Immun 1987; 55(2): 373–80
- Orskov I, Ferencz A, Orskov F. Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli. (Letter) Lancet 1980; 1 (8173): 887
- Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, et al. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 1989; 320(12): 773–7
- Schaeffer AJ, Jones JM, Dunn JK. Association of vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary-tract infections. N Engl J Med 1981; 304(18): 1062–6
- Parsons CL, Greenspan C, Mulholland SG. The primary antibacterial defense mechanism of the bladder. Invest Urol 1975; 13(1): 72–8
- Freedman LR, Becson TB. Experimental pyelonephritis. IV. Observations on infections resulting from direct inoculation of bacteria in different zones of the kidney. Yale J Biol Med 1958; 30:406–14
- Rene P, Dinolfo M, Silverblatt FJ. Serum and urogenital antibody responses to Escherichia coli pili in cystitis. Infect Immun 1982; 38(2): 542–7
- Measley RE Jr, Levison ME. Host defense mechanisms in the pathogenesis of urinary tract infection. Med Clin North Am 1991; 75(2): 275–86
- Vejlsgaard R. Studies on urinary infection in diabetics. I. Bacteriuria in patients with diabetes mellitus and in control subjects. Acta Med Scand 1966; 179(2): 173–82
- Bryan CS, Reynolds KL. Community-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol 1984; 132(3): 490–3
- Bryan CS, Reynolds KL. Hospital-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol 1984; 132(3): 494–8
- Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993; 329(18): 1328–34
- Fihn SD, Latham RH, Roberts P, et al. Association between diaphragm use and urinary tract infection. JAMA 1985; 254(2): 240–5
- Strom BL, Collins M, West SL, et al. Sexual activity, contraceptive use, and other risk factors for symptomatic and asymptomatic bacteriuria: a case-control study. Ann Intern Med 1987; 107(6): 816–23
- Stapleton A, Latham RH, Johnson C, et al. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection: a randomized, double-blind, placebo-controlled trial. JAMA 1990; 264(6): 703–6
- Harding GK, Ronald AR, Nicotic LE, et al. Long-term antimicrobial prophylaxis for recurrent urinary tract infection in women. Rev Infect Dis 1982; 4(2): 438–43
- Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329(11): 753–6
- Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 1995; 9(1): 25–51
- Warten JW, Anthony WC, Hoopes JM, et al. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA 1982; 248(4): 454–8
- Zhanel GG, Harding GK, Guay DR. Asymptomatic bacteriuria: which patients should be treated? Arch Intern Med 1990; 150(7): 1389–96
- Andriole VT, Patterson TF. Epidemiology, natural history, and management of urinary tract infections in pregnancy. Med Clin North Am 1991; 75(2): 359–73